Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Conditions: Heart Failure; Overactive Bladder; Incontinence Interventions: Drug: Extended release torsemide; Drug: Immediate release torsemide; Drug: Extended release torsemide placebo; Drug: Immediate release torsemide placebo Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
Conditions: Urinary Bladder, Overactive; Overactive Bladder; Urinary Incontinence, Urge Interventions: Behavioral: urotherapy; Drug: Solifenacin Succinate; Drug: Vitamin D3 Sponsors: Xing Liu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
rTMS in Overactive Bladder
Conditions: Overactive Bladder; Overactive Bladder Syndrome; Urge Incontinence; Urgency-frequency Syndrome; Urinary Incontinence; Urinary Incontinence, Urge Interventions: Device: Transcranial Magnetic Stimulation Sponsors: The Methodist Hospital Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Management of OAB in Female Patients .
Conditions: Overactive Bladder Interventions: Drug: Solfenacin; Drug: Mirabegron; Drug: Tadalafil 5mg Sponsors: Elsayed Abdelhalim Elsayed Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Acupuncture Combined With Mirabegron in the Treatment of OAB
Conditions: Overactive Bladder Interventions: Drug: 50 mg of mirabegron; Combination Product: acupuncture combined with mirabegron. Sponsors: The Affiliated Ganzhou Hospital of Nanchang University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB)
Conditions: Overactive Bladder Interventions: Drug: Mirabegron 50 MG; Drug: Oxybutynin Chloride 5 MG Sponsors: Seoul National University Hospital; Il-Yang Pharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Cyclic Versus Continuous Sacral Neuromodulation for LUTS
Conditions: Overactive Bladder Syndrome Interventions: Device: Cyclic SNM; Device: Continuous SNM Sponsors: David Sheyn; Northwestern University; University of Louisville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Effectiveness of Oral Boldo in Women With Overactive Bladder
Conditions: Urinary Bladder, Overactive Interventions: Drug: Oxybutynin Pill; Dietary Supplement: Boldo supplement Sponsors: Universidad de Valparaiso; Uro Medical Corporation Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
Conditions: Multiple Sclerosis; Overactive Bladder Syndrome Interventions: Device: TTNS (Transcutaneous tibial nerve stimulation); Device: PNS (Parasacral nerve stimulation); Device: Sham stimulation; Behavioral: Behavioral treatment Sponsors: Prof. Dr. Cemil Tasc ıoglu Education and Research Hospital Organization; Marmara University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
Conditions: Overactive Bladder; Overactive Bladder Syndrome Interventions: Drug: mirabegron 50 mg daily; Device: Extracorporeal magnetic innervation (active treatment); Device: Extracorporeal magnetic innervation (sham treatment) Sponsors: Serdinsek Tamara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)
Conditions: Overactive Bladder; Deprescribing; PIMS Interventions: Other: deprescribing-intervention Sponsors: Anne Estrup Olesen; University College of Northern Denmark Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Improving Overactive Bladder Treatment Access and Adherence
Conditions: Overactive Bladder Syndrome; Urinary Incontinence Interventions: Behavioral: Patient Engagement Tool Sponsors: Stanford University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
Conditions: Urinary Incontinence; Urinary Incontinence, Urge; Fecal Incontinence; Fecal Incontinence With Fecal Urgency; Nocturia; Urinary Frequency More Than Once at Night; Bowel Disorders Functional; Incontinence, Nighttime Urinary Interventions: Device: UCon-Bar Sponsors: InnoCon Medical; Aarhus University Hospital; Odense University Hospital; Herlev Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder
Conditions: Overactive Bladder Syndrome Interventions: Device: Acupuncture; Other: pelvic floor exercises Sponsors: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
RF in the Treatment OAB in UUI- a Prospective Randomized Placebo Controlled Study
Conditions: Overactive Bladder Syndrome; Urge Incontinence Interventions: Device: study group; Device: placebo (sham control) Sponsors: Ginekologija Dr. Frani ć, D.O.O. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
